Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts
Open Access
- 28 February 2003
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (3) , 798-806
- https://doi.org/10.1002/art.10953
Abstract
Objective To examine the mechanism of collagen induction by connective tissue growth factor (CTGF), a profibrotic cytokine overexpressed in the skin of patients with systemic sclerosis (SSc). Methods Dermal fibroblasts from 7 SSc patients and 7 matched healthy adult donors were stimulated with CTGF in the presence or absence of the culture-medium supplement, insulin–transferrin–selenium (ITS). Expression of collagen protein was analyzed by a 3H-proline incorporation assay. To identify the signaling pathways mediating CTGF induction of collagen, pharmacologic inhibitors were used, including rottlerin, a protein kinase Cδ (PKCδ) inhibitor. Results Collagen levels in both SSc and normal fibroblasts were increased after treatment with transforming growth factor β in serum-free medium, whereas no stimulation was observed following addition of CTGF. In the presence of ITS, CTGF (2.5 ng/ml) potently stimulated collagenous protein levels in SSc cell lines (n = 5); however, CTGF was not stimulatory in the majority of normal fibroblasts (n = 6). ITS alone induced collagen levels in normal fibroblasts to the levels observed in SSc skin fibroblasts, thereby diminishing the hallmark difference in basal collagen levels in these cell types. Insulin was the ITS component responsible for promoting the basal and CTGF stimulation of collagenous proteins. Rottlerin, the PKCδ inhibitor, down-regulated collagen synthesis in normal and SSc fibroblasts cultured in ITS, and inhibited the stimulatory effects of CTGF in cooperation with insulin or of insulin (500 ng/ml) alone. Conclusion Increased responsiveness of SSc fibroblasts to CTGF-mediated collagen synthesis requires the costimulatory activation of insulin signaling pathways to induce matrix production. Blockade of this effect via rottlerin may suggest that PKCδ is a downstream signaling molecule necessary for CTGF stimulation of collagen synthesis.Keywords
This publication has 28 references indexed in Scilit:
- TGF-β and CTGF have overlapping and distinct fibrogenic effects on human renal cellsAmerican Journal of Physiology-Renal Physiology, 2002
- The Low Density Lipoprotein Receptor-related Protein/α2-Macroglobulin Receptor Is a Receptor for Connective Tissue Growth FactorJournal of Biological Chemistry, 2001
- Activation of Latent Transforming Growth Factor β1 by Stromelysin 1 in Extracts of Growth Plate Chondrocyte-Derived Matrix VesiclesJournal of Bone and Mineral Research, 2001
- In vitro evidence for differential involvement of CTGF, TGFβ, and PDGF‐BB in mesangial response to injuryNephrology Dialysis Transplantation, 2001
- Insulin Induces Specific Interaction between Insulin Receptor and Protein Kinase C in Primary Cultured Skeletal MuscleMolecular Endocrinology, 2001
- Connective Tissue Growth Factor: What's in a Name?Molecular Genetics and Metabolism, 2000
- Expression of TGF-β1, -β2 and -β3 in localized and systemic sclerodermaJournal of Dermatological Science, 1999
- The Connective Tissue Growth Factor/Cysteine- Rich 61/Nephroblastoma Overexpressed (CCN) FamilyEndocrine Reviews, 1999
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994
- Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.The Journal of cell biology, 1991